Inclusion criteria:
Adults (male and female) in the age range of 18-55 years
Having a body mass index of 25-35 kg/m2
With diagnosis of metabolic dysfunction–associated steatotic liver disease (MASLD) based on liver ultrasound by a gastroenterologist
Willing to participate in the study
Exclusion criteria:
Regular use of nonsteroidal anti-inflammatory drugs, antibiotics, steroids (excluding topical and inhaled drugs), metformin, colchicine, hormonal drugs such as high doses of estrogen within the past 3 months, use of chemical or herbal weight loss drugs and use of hepatotoxic drugs such as phenytoin, amiodarone, levothyroxine, lithium, statins, blood pressure drugs, lipid-lowering drugs, use of multivitamin-mineral supplements, folate, antioxidants such as vitamin E and omega-3 supplements
Diagnosed pathological conditions affecting the liver such as viral hepatitis, acute or chronic liver failure, cholestasis, liver transplantation
Having hemochromatosis, Wilson disease, Alpha-1 antitrypsin, diabetes, heart failure, renal, intestinal, thyroid dysfunction, biliary disease, PCOS, autoimmune diseases and malabsorption diseases such as Crohn's, the presence of any diagnosed neoplasia or malignancy, having symptoms of infectious or inflammatory disease
Acute systemic disease, cystic fibrosis, history of gastrointestinal surgery within the past year, irritable bowel syndrome, celiac disease
Pregnancy, breastfeeding, menopause
History of alcohol and tobacco use